Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Burgel (Paris, France). What new biomarkers are on the horizon for severe exacerbations?. Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC

Member's Comments

No comment yet.

Related content which might interest you: Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019 Year: 2019 Do cardiac biomarkers predict long-term outcomes from exacerbations of COPD? Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Does past experience predict future exacerbations in adults with asthma? Source: Annual Congress 2010 - Therapy and health economics of asthma and COPD Year: 2010 Should the number of acute exacerbations in the previous year be used to guide treatments in COPD? Source: Eur Respir J, 57 (2) 2002122; 10.1183/13993003.02122-2020 Year: 2021 Aetiology of exacerbations of asthma and COPD: new viruses, new mechanisms Source: Annual Congress 2010 - Severe exacerbations in asthma and COPD: new causes, mechanisms and models of care Year: 2010 Are severe and moderate exacerbations different entities? Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC Year: 2021 How can we better treat infective exacerbations of COPD? Source: Annual Congress 2012 - Prevention and treatment of infective exacerbations of COPD Year: 2012 What is the best biomarker of COPD stability? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Is CRP a reliable diagnostic tool for infective exacerbations of COPD? Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Is the GOLD guideline for diagnosing obstruction in COPD discriminatory in predicting severe future COPD-related exacerbations and death? Source: Breathe, 17 (4) 210046; 10.1183/20734735.0046-2021 Year: 2021 Impact of stable state symptoms on the future burden of COPD exacerbations Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Clinical clustering of COPD patients is useful to predict future COPD exacerbations Source: International Congress 2018 – New predictors of morbidity and mortality in COPD Year: 2018 Recommended new therapies for severe asthma and the future Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop Year: 2014 How can treatable traits be used in severe exacerbations? Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC Year: 2021 Who should receive which biologic and why? Current and future approaches in severe asthma patients Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what? Year: 2021 Recommendations of new therapies for severe asthma and the future Source: Annual Congress 2013 –ERS/ATS Task Force report on severe asthma Year: 2013 A new early predictive index for hospitalisation in acute exacerbations of asthma Source: Annual Congress 2008 - Mechanical ventilation and airway management Year: 2008 Prediction of future COPD exacerbations - DOSE index or a history of exacerbations? Source: International Congress 2018 – Primary care management of COPD Year: 2018